Fujisawa, Japan

Noribumi Tomiyama

This inventor holds 7 USPTO granted patents and 2 EPO patents. Top assignees: Roche Vitamins Inc., Dsm Assets B.v.. Active years: 2000-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noribumi Tomiyama. Retrieved from https://idiyas.com/inventor/noribumi-tomiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 85.7


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2000-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Noribumi Tomiyama: Pioneering Inventor from Fujisawa

Introduction: Noribumi Tomiyama is a distinguished inventor hailing from Fujisawa, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tomiyama's recent patents focus on advancements in robotics, artificial intelligence, and sustainable energy solutions, showcasing his commitment to creating a more efficient and eco-friendly future.

Career Highlights: With over two decades of experience in the tech industry, Tomiyama has held key positions in leading research institutions and multinational companies, driving forward cutting-edge projects and spearheading innovative initiatives.

Collaborations: Throughout his career, Tomiyama has collaborated with top engineers, scientists, and researchers from around the globe, fostering a culture of creativity and excellence in all his projects.

Conclusion: Noribumi Tomiyama's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventions, inspiring the next generation of inventors to dream big and create change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…